Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-081226
Filing Date
2007-04-16
Accepted
2007-04-16 06:11:35
Documents
5
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1321059
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 1687
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 6874
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 7365
5 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex32.htm EX-32 6369
  Complete submission text file 0001193125-07-081226.txt   1344813
Mailing Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134
Business Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134 702-248-1174
CardioVascular BioTherapeutics, Inc. (Filer) CIK: 0001303497 (see all company filings)

EIN.: 330795984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51172 | Film No.: 07767123
SIC: 2834 Pharmaceutical Preparations